1Soll All. Medical treatment of peptic ulcer disease. Practice guidelines[J].JAMA,1996,622-629.
2Liu WZ,Xiao SD,Shi Y,et al.Furazolidone-containing shortterm triple therapies are effective in the treatment of Helicobacter pylori infection[J].Aliment Pharmacol Ther,1999,13 (3):317-322.
3Mansour-Ghanaei F,Fallah M S,Shafaghi A.Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline & furazolidone vs.metronidazole & amoxicillin in omeprazole based triple therapy[J].Med Sci Monit,2002,8(3):127-130.
4Lind T,Megraud F,Unge P,et al.The MACH2 study:role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies[J].Gastroenterlogy,1999,116:248-253.
5Schwartz H,Krause R,Siepman N,et al.Seven-day triple therapy with lansoprazole,clarithromycin,and metronidazole for the cure of Helicobacter pylori infection:a short report[J].Helicobacter,1996,1:251-254.
6Moayyedi P,Langworthy H,Shanah K,et al.Comparision of one or two weeks of lansoprazole,amoxicillin,and clarithromycin in the treatment of Helicobacter pylori[J].Helicobacter,1996,1(2):71-78.
7Dammann HG.Eradication of H.pylori with pantoprazole,clarithromycin,and metronidazole in duodenal ulcer patients:a head-to-head comparison between two regimens of different duration[J].Helicobacter,2000,5(1):41-51.
8Javier PG,Sam K,Xavier C,et al.Pantoprazole based therapies in Helicobacter pylori eradication:a systematic review and Meta-analysis[J].European Journal of Gastroenterology & Hepatology,2004,16 (1):89-99.
9Hawkey CJ,Atherton JC,Treichel HC,et al.Safety and efficacy of 7-day rabeprazole-and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease[J].Aliment Pharmacol Ther,2003,17(8):1065-1074.
10Gisbert JP,Dominguez-Munoz A,Dominguez-Martin A,et al.Esomeprazole-based therapy in Helicobacter pylori eradication:any effect by increasing the dose of esomeprazole or prolonging the treatment[J].American Journal of Gastroenterology,2005,100(9):1935-1940.
6Williams MP, Pounder RE. Review article: the pharmacology of rabeprazole[J]. Aliment Pharmacol Ther, 1999, 13(Suppl 3): 3-10.
7Human A, Wei J, Broom C, et al. Effect of oral pantoprazole on 24 hour intragastric acidity and plasma gastrin profiles[J]. Alimem Pharmacol Ther, 1992, 6(3): 373-380.
8Cam JJ,Salas M,Ward A.Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansopra- zole, rabeprazole, and pantoprazole compared with omeprazole, raniti- dine, and placebo: evidence from randomized clinical trims [J]. Clinical Therapeutics, 2011 (18) : 362-391.
9Fresnadillo Martinez MJ,Rodriguez Rincon M,Blazquez de Castro AM,et al.Comparative evaluation of Selective and nonselective media for prima- ry isolation of Helicobacter pylori from gastric biopsies[J]. Helicobacter, 2014(26) : 1988-2031.
10Gilmer TP, O' Conner PJ, Manning WG, et al. The cost to health plans of poor glycemic control[J], diabetes care , 2012,20(2):1847-1853.
